Clinical Trial Update: Exogenous Ketone Supplementation in ICU Delirium [Phase 1]

View source ↗

Summary

Phase 1 trial evaluating safety and feasibility of exogenous ketone supplementation to treat ICU delirium in critically ill patients; not yet recruiting.

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Critical Illness
• Icu Delirium

Drugs mentioned

• Exogenous ketone supplementation

Snippet

Sponsor: Vanderbilt University Medical Center | Conditions: ICU Delirium, Critical Illness | Phase 1 | Status: NOT_YET_RECRUITING